分子診断業界の状況 2005

Abstract

The impact of SNPs and other molecular diagnostic markers is now being felt--this will grow as more molecular markers are validated and launched for their diagnostic and prognostic value.

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. We present an assessment of all the technologies of value in this space and which market segments are impacted and affected by these technologies.

Furthermore, in this report are presented qualitative and quantitative market analysis of the molecular diagnostics space. We present total industry revenues, growth rates, and the various qualitative drivers that are contributing to the growth of the marketplace.

Table of Contents

• Executive Summary
• Molecular Diagnostics: Overview of the space
• Value drivers of molecular diagnostics
• Growth drivers of molecular diagnostics
• Quantitative Market Summary-I
• Quantitative Market Summary-II
• Quantitative Market Summary-III
• Types of molecular diagnostic tests
• Emerging themes in molecular diagnostics
• Technologies, Trends, & Market Segments in the Molecular Diagnostics Space
• Molecular diagnostics testing
• Molecular diagnostics (Vocabulary and acronyms)
• Molecular targets
• Testing formats
• Testing arenas
• Infectious disease
• Human genetic targets
• Genetics
• Test development
• Samples
• Sample preparation
• PCR
• Real-time PCR
• SYBR Green
• MultiCode RTx
• Taq-Man
• HybProbe
• Molecular Beacons
• bDNA
• TMA
• Invader
• ELISA Formats
• Solid Support Systems
• 2-D arrays
• 2-D chips
• MultiCode PLx
• Tag-It
• Signature
• Comparisons
• Sequencing
• Automation
• Real-time PCR automation
• TMA automation
• MultiCode Automation
• Production and Regulatory Acronyms
• Production
• Approval Processes in the Molecular Diagnostics Space
• Test development standards
• FDA approved tests
• Approval process US
• Approval process-European Union
• Approval process Japan
• Molecular diagnostics market analysis
• Where are we today
• Evolution of molecular diagnostics
• Types of tests/products
• R&D journey of a genomics test
• Molecular diagnostics tests revenues
• Adoption rates of molecular diagnostics tests
• Quantitative market summary-I
• Quantitative market summary-II
• Quantitative market summary-III
• Quantitative market summary-IV
• Evolution of molecular diagnostic technologies
• Molecular diagnostics: Where is the market heading?
• Molecular diagnostics in relation to other genomics-based approaches
• Biological targets for development of molecular diagnostics
• Development of molecular diagnostic tests
• Company Profiles
• Abbott Diagnostics
• Bayer Diagnostics
• Biosite Diagnostics
• Celera Diagnostics
• Cepheid
• DiaDexus
• DiagnoSwiss SA
• Digene Corporation
• Genaissance Pharmaceuticals, Inc.
• Gen-Probe, Inc.
• Innogenetics NV
• Myriad Genetics
• Quest Diagnostics
• Roche Diagnostics
• Veridex, LLC
• Other market participants with product offerings-interest in the molecular diagnostics space
• Nomenclature and research methodology